Today's pre-market stock movers: BP, CHGG, PFE, EL and more

• $Belite Bio(BLTE.US)$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)

• $Atkore(ATKR.US)$ +12.11% (earnings reports)

• $AST SpaceMobile(ASTS.US)$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)

• $Harmonic(HLIT.US)$ +7.56% (earnings reports)

• $The Chemours(CC.US)$ +7.2% (earnings reports)

• $Stoke Therapeutics(STOK.US)$ +6.7% (presents new in-vivo data)

• $Taysha Gene Therapies(TSHA.US)$ +5.6% (granted orphan drug designation from the European Commission for TSHA-120)

• $LumiraDx(LMDX.US)$ +5% (stock offering)

• $BP PLC(BP.US)$ +4.8% (BP books $25.5 bln impairments on Russia exit)

• $Sanmina(SANM.US)$ +3.8% (also increases buyback authorization by $200 mln)

• $Genworth Financial(GNW.US)$ +3.2% ($350 mln share repurchase auth)

• $Imperial Oil(IMO.US)$ +1.6% (announces terms of its substantial issuer bid for up to CAD2.5 bln)

• $Carnival(CCL.US)$ +1.2% (celebrates restart of entirety of Carnival Cruise Une fleet)

• $MPLX LP(MPLX.US)$ +1.2% (Whistler Pipeline expansion reaches final investment decision)

• $ACADIA Pharmaceuticals(ACAD.US)$ +1% (FDA Advisory Committee to host meeting to review sNDA for NUPLAZID on June 17)

• $Agora(API.US)$ +4.2% (upgraded to Overweight from Equal-Weight at Morgan Stanley)

• $Jakks Pacific(JAKK.US)$ +3.8% (upgraded to Outperform from Market Perform at BMO Capital Markets)

• $argenx SE(ARGX.US)$ +2.6% (upgraded to Overweight from Equal-Weight at Morgan Stanley)

• $Shenandoah Telecommunications Co(SHEN.US)$ +2.6% (upgraded to Strong Buy from Outperform at Raymond James)

• $Chegg(CHGG.US)$ -39.8% (cut its revenue outlook, saying current economic conditions are prompting consumers to prioritize “earning over learning.”)

• $EverQuote(EVER.US)$ -27.47% (earnings reports)

• $Hayward Holdings(HAYW.US)$ -12.3% (stock offering)

• $Estee Lauder(EL.US)$ -9.07% (earnings reports)

• $DBV Technologies(DBVT.US)$ -6.1% (establishes At-The-Market offering program)

• $Freshpet(FRPT.US)$ -4.4% (also launches $350 mln proposed follow-on offering)

• $Incyte(INCY.US)$ -3.8% (earnings reports)

• $CECO Environmental(CECE.US)$ -2.1% (files for $150 mln mixed securities shelf offering)

• $DuPont(DD.US)$ -2.1% (earnings reports)

• $Pfizer(PFE.US)$ -1.1% (reported a first-quarter profit of $1.62 per share, 15 cents a share above estimates. Revenue topped forecasts as well. The drugmaker cut its full-year outlook due to an accounting change)

• $Carvana(CVNA.US)$ -4.8% (downgraded to Equal Weight from Overweight at Wells Fargo)

• $Matterport(MTTR.US)$ -4.3% (downgraded to Neutral from Outperform at Wedbush)

• $DocuSign(DOCU.US)$ -4.1% (downgraded to Underperform from Neutral at Wedbush)

• $C3.ai(AI.US)$ -3.2% (downgraded to Neutral from Outperform at Wedbush)

• $Kellanova(K.US)$ -2% (downgraded to Underweight from Neutral at Piper Sandler)

• $Tyson Foods(TSN.US)$ -2% (downgraded to Underweight from Neutral at Piper Sandler)